{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:36:03Z","timestamp":1769610963869,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.cancergencyto.2006.05.016","type":"journal-article","created":{"date-parts":[[2006,10,30]],"date-time":"2006-10-30T16:51:16Z","timestamp":1162227076000},"page":"1-8","source":"Crossref","is-referenced-by-count":10,"title":["Association between telomere length and BCL2 gene rearrangements in low- and high-grade non-Hodgkin lymphomas"],"prefix":"10.1016","volume":"171","author":[{"given":"Alejandra Silvina Hayde\u00e9","family":"Cottliar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Fernanda","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Narbaitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma Rosa","family":"Slavutsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2006.05.016_bib1","first-page":"197","article-title":"Telomere maintenance in tumour cells","volume":"28","author":"Bacchetti","year":"1996","journal-title":"Cancer Surv"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0047-6374(00)00095-6","article-title":"Telomerase and mammalian ageing: a critical appraisal","volume":"114","author":"Goyns","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(00)80760-6","article-title":"Mammalian telomeres end in a large duplex loop","volume":"97","author":"Griffith","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib4","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1038\/sj.onc.1208119","article-title":"Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: whole-genome evidence from multiple cell lines","volume":"23","author":"Deng","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib5","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours","first-page":"118","article-title":"Mature B-cell neoplasms","author":"Harris","year":"2001"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib6","series-title":"Cancer incidence in five continents. Vol. 7. IARC Scientific Publication 143","author":"Parkin","year":"1997"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib7","first-page":"26","article-title":"FLIPI and histological subtype of the most important predicting factors of histological transformation in follicular lymphoma","volume":"16","author":"Gine","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib8","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.82.21.7439","article-title":"Nucleotide sequence of a t(14;18) chromosome breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18","volume":"82","author":"Cleary","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.164.1.315","article-title":"Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas","volume":"164","author":"Cleary","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1098-2264(199801)21:1<17::AID-GCC4>3.0.CO;2-B","article-title":"Refinement of the BCL-2\/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets","volume":"21","author":"Akasaka","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9440(10)64905-X","article-title":"High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection","volume":"160","author":"Albinger-Hegyi","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bcmd.2003.10.001","article-title":"Incidence of BCL-2 gene rearrangements in Argentinean non-Hodgkin lymphoma patients: increased frequency of breakpoints outside of MBR and MCR","volume":"32","author":"Noriega","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.0.CO;2-5","article-title":"BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy","volume":"60","author":"Reed","year":"1996","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib14","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/emboj\/20.10.2596","article-title":"A novel role for the Bcl-2 protein family: specific suppression of the RAD51 recombination pathway","volume":"20","author":"Saintigny","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ncb1215","article-title":"Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity","volume":"7","author":"Youn","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib16","first-page":"1860","article-title":"Report of the Committee on Hodgkin's Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hon.2900010209","article-title":"Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method","volume":"1","author":"Mann","year":"1983","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1034\/j.1600-0609.2003.00157.x","article-title":"Telomere shortening in patients with plasma cell disorders","volume":"71","author":"Cottliar","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib19","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V78.12.3275.3275","article-title":"All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment","volume":"78","author":"Gribben","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1054\/bjoc.1999.0970","article-title":"Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse","volume":"82","author":"Remes","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0092-8674(01)00504-9","article-title":"The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability","volume":"107","author":"Hemann","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.bjc.6600438","article-title":"Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres","volume":"87","author":"Gisselsson","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-4608(94)00222-W","article-title":"Chromosome rearrangements at telomeric level in hematologic disorders","volume":"83","author":"Temperani","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib24","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1182\/blood-2003-12-4412","article-title":"Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders","volume":"103","author":"Ladetto","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib25","first-page":"876","article-title":"Genetic determination of telomere size: a twin study of three age groups","volume":"55","author":"Slagboom","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/excr.1999.4398","article-title":"Telomere length in fibroblasts and blood cells from healthy centenarians","volume":"10","author":"Mondello","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1044-579X(03)00015-4","article-title":"Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions","volume":"13","author":"Lossos","year":"2003","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0046-8177(03)00350-2","article-title":"Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"34","author":"Boonstra","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V80.3.758.758","article-title":"MYC rearrangements in histologically progressed follicular lymphomas","volume":"80","author":"Yano","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib30","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1073\/pnas.132253599","article-title":"Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes","volume":"99","author":"Lossos","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V96.2.635","article-title":"Higher-grade transformation of follicular center lymphoma is associated with somatic mutation of the 5\u2032 noncoding regulatory region of the BCL-6 gene","volume":"96","author":"Lossos","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib32","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1182\/blood.V88.10.3937.bloodjournal88103937","article-title":"Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated BCL-2 gene","volume":"88","author":"Matolcsy","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib33","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16INK4A gene inactivation by deletion, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas","volume":"9","author":"Pinyol","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib34","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib35","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1073\/pnas.1137463100","article-title":"Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy","volume":"100","author":"Elenitoba-Johnson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib36","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"P53 mutations are associated with histologic transformation of follicular lymphoma","volume":"82","author":"Lo Coco","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib37","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphoma","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib38","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood.V95.6.1883","article-title":"Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry","volume":"95","author":"Brummendorf","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.leu.2403616","article-title":"Dysregulated expression of the major telomerase components in leukaemic stem cells","volume":"19","author":"Drummond","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib40","first-page":"3557","article-title":"Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes","volume":"54","author":"Ohyashiki","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1096-8652(199712)56:4<266::AID-AJH12>3.0.CO;2-7","article-title":"Telomere length in myelodysplastic syndromes","volume":"56","author":"Boultwood","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib42","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood.V78.6.1552.1552","article-title":"Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis","volume":"78","author":"Zelenetz","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<85::AID-GCC11>3.0.CO;2-9","article-title":"Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes","volume":"27","author":"Vaandrager","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib44","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1182\/blood.V93.9.3081","article-title":"Correlation of BCL-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma","volume":"93","author":"Lopez-Guillermo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib45","first-page":"574a","article-title":"Comparison of t(14;18) positive and t(14;18) negative follicular lymphoma (FL): clinical characteristics, outcome and cytogenetics","volume":"96","author":"Sehn","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib46","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/sj.leu.2402707","article-title":"Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics","volume":"16","author":"Jardin","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib47","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2141.2003.04086.x","article-title":"Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes","volume":"120","author":"Horsman","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib48","first-page":"847a","article-title":"Cytogenetic analysis of follicular lymphoma: Chromosome instability associated with t(14;18)(q32;q21) positive and negative subsets, histology and transformations","volume":"102","author":"Nanjangud","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/1042819021000050052","article-title":"Incidence and clinical significance of Bcl-2\/IgH rearrangements in follicular lymphoma","volume":"44","author":"Montoto","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib50","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.leu.2402568","article-title":"Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?","volume":"16","author":"Buchonnet","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib51","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMra021902","article-title":"Rules for making human tumor cells","volume":"347","author":"Hahn","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2006.05.016_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3835(02)00708-5","article-title":"Telomerase inhibition as cancer therapy","volume":"194","author":"Saretzki","year":"2003","journal-title":"Cancer Lett"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806003694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806003694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T20:41:42Z","timestamp":1587242502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460806003694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0165460806003694"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.05.016","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}